Back to search
Farber's Lipogranulomatosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Farber's Lipogranulomatosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Farber's Lipogranulomatosis trials you may qualify forTo identify the most common underlying causes of non-inflammatory arthropathy in children presenting to Assiut University Children Hospital for through clinical…
Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Farber disease from the blood
The primary objective of this study is to establish the natural history of Farber disease (acid ceramidase deficiency) through the collection and analysis of re…